Home › Blood Cancers › Nebraska
Blood Cancers clinical trials in Nebraska
10 studies for Blood Cancers are looking for participants at sites in Nebraska.
Cities in Nebraska
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- CHI Health Saint Francis, Grand Island
- CHI Health Good Samaritan, Kearney
- Alegent Health Immanuel Medical Center, Omaha
- and 2 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
- Nebraska Medicine-Bellevue, Bellevue
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
RecruitingObservational study
All ages · All sexes · Updated Sep 17, 2026 · NCT04242095A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
- The University of Nebraska Medical Center, Omaha
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT07195916Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- University of Nebraska Medical Center, Omaha
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 20, 2026 · NCT06001788A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
- University of Nebraska Medical Center, Omaha
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT06823167A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Nebraska Medical Center, Omaha
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545Halt Aging in Survivors of Blood Cancers
- University of Nebraska Medical Center, Omaha
Recruiting
Ages 50 and older · All sexes · Updated Jul 1, 2026 · NCT07292272Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
- Nebraska Cancer Specialists, Omaha
- University of Nebraska Medical Center, Omaha
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jun 24, 2026 · NCT04068597CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
- Fred and Pamela Buffett Cancer Center, Omaha
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT03328078Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
- University of Nebraska Medical Center, Omaha
RecruitingPhase 2
Ages 60 and older · All sexes · Updated Dec 15, 2025 · NCT06799195From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.